HU174961B - Sposob poluchenija proizvodnykh piperidil-khinazolina - Google Patents

Sposob poluchenija proizvodnykh piperidil-khinazolina

Info

Publication number
HU174961B
HU174961B HU75PI483A HUPI000483A HU174961B HU 174961 B HU174961 B HU 174961B HU 75PI483 A HU75PI483 A HU 75PI483A HU PI000483 A HUPI000483 A HU PI000483A HU 174961 B HU174961 B HU 174961B
Authority
HU
Hungary
Prior art keywords
piperidyl
preparing
quinazoline derivatives
quinazoline
derivatives
Prior art date
Application number
HU75PI483A
Other languages
English (en)
Hungarian (hu)
Inventor
John C Danilewicz
Anthony G Evans
Allan L Ham
Colin Thomson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HU174961B publication Critical patent/HU174961B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU75PI483A 1974-07-25 1975-07-18 Sposob poluchenija proizvodnykh piperidil-khinazolina HU174961B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3280574 1974-07-25

Publications (1)

Publication Number Publication Date
HU174961B true HU174961B (hu) 1980-04-28

Family

ID=10344259

Family Applications (1)

Application Number Title Priority Date Filing Date
HU75PI483A HU174961B (hu) 1974-07-25 1975-07-18 Sposob poluchenija proizvodnykh piperidil-khinazolina

Country Status (7)

Country Link
AT (1) AT344178B (de)
BE (1) BE831654A (de)
CS (1) CS192549B2 (de)
ES (4) ES439690A1 (de)
HU (1) HU174961B (de)
PL (6) PL104615B1 (de)
SU (5) SU578874A3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070004763A1 (en) * 2005-06-10 2007-01-04 Nand Baindur Aminoquinoline and aminoquinazoline kinase modulators

Also Published As

Publication number Publication date
PL103789B1 (pl) 1979-07-31
AT344178B (de) 1978-07-10
PL103791B1 (pl) 1979-07-31
PL103798B1 (pl) 1979-07-31
ES455985A1 (es) 1978-06-16
PL193423A1 (pl) 1978-04-24
SU613723A3 (ru) 1978-06-30
PL103797B1 (pl) 1979-07-31
PL193420A1 (pl) 1978-04-24
PL193422A1 (pl) 1978-06-05
SU858563A3 (ru) 1981-08-23
ES455986A1 (es) 1978-06-01
SU625606A3 (ru) 1978-09-25
ES455984A1 (es) 1978-06-01
PL99427B1 (pl) 1978-07-31
SU634671A3 (ru) 1978-11-25
BE831654A (fr) 1976-01-23
ES439690A1 (es) 1977-07-01
SU578874A3 (ru) 1977-10-30
CS192549B2 (en) 1979-08-31
PL104615B1 (pl) 1979-08-31
ATA525275A (de) 1977-11-15
PL193419A1 (pl) 1978-04-24
PL193421A1 (pl) 1978-04-24

Similar Documents

Publication Publication Date Title
YU37156B (en) Process for preparing 1-z3-(naphthyl-1-yloxy)-2-hydroxy-propylc-piperazine derivatives
CS183829B2 (en) Process for preparing thienamycine
HU171059B (hu) Sposob poluchenija piridazinil-benzimidazolov
HU173590B (hu) Sposob poluchenija proizvodnykh d-6-metil-8-tiometil-ehrgolina
HU173739B (hu) Sposob poluchenija proizvodnykh tienotiazina
YU39113B (en) Process for preparing 2-arylamino-2-imidazoline derivatives
HU172431B (hu) Sposob poluchenija proizvodnykh fenola
HU172493B (hu) Sposob poluchenija proizvodnykh tienobenzodiazepina
CS189730B2 (en) Process for preparing o-cyanazodyes
CS191290B2 (en) Process for preparing aminoalkylphenyletheres
HU174348B (hu) Sposob poluchenija proizvodnykh 13-tia-prostaglandinov
HU173740B (hu) Sposob poluchenija proizvodnykh aza-digidro-prostaglandina
CS193518B2 (en) Process for preparing moenomycine
CS188259B2 (en) Process for preparing 2-anilinooxazoles
CS188984B2 (en) Process for preparing 3-fluorbenzodiazepines
GB1486844A (en) Process for preparing 7beta-acylamino-7alpha-alkoxy-cephalosporins
HU174300B (hu) Sposob poluchenija proizvodnykh 1-acil-4-/o-galofenil/-tiosemikarbazida
HU172146B (hu) Sposob poluchenija proizvodnykh cinnolina
YU293975A (en) Process for obtaining phenylpyridylamine derivatives
YU39338B (en) Process for preparing indolo-quinolizisdine derivatives
YU107875A (en) Process for preparing indolinoquinolyzine derivatives
YU157375A (en) Process for preparing new ergopetine derivatives
CS191291B2 (en) Process for preparing 3-methylencepham-sulphoxides
CS188253B2 (en) Process for preparing 2-methyl-3-hydroxy-4-ethylaminomethyl-5-methylmercaptomethyl-pyridine
CS188967B2 (en) Process for preparing 6-chlor-2-chlormethyl-4-phenylquinazolin-3-oxide